Olink Bioscience Appoints Patrik Dahlén as Chairman of the Board
Olink Bioscience has announced the appointment of Dr. Patrik Dahlén as Chairman of the Board. As the former CEO of global cancer diagnostics company Dako and with experience from several smaller fast developing biotech companies, Dr. Dahlén will bring invaluable industry insight and a fresh perspective to Olink Bioscience continued expansion. Professor Ulf Landegren, co-founder and the company´s former Chairman of the Board will continue to serve on the BoD and he will continue to bring the company valuable contacts with the scientific community in Uppsala and internationally
Dr. Dahlén has occupied high level positions within the diagnostics and life sciences sector for over 15 years. Prior to his four year tenure at Dako from 2005 to January 2009 Dr. Dahlen was CEO of the Danish biotech company Biolmage and previous to that president of lifesciences and senior vice president at PerkinElmer. Dr. Dahlen currently holds other board positions which include Proxeon, DxS Diagnostics, and has been a board member for DakoCytomation and Cantion.
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.